Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens

New England Journal of Medicine

Volumn 345, Issue 16, 2001, Pages 1155-1160

  Clifford McDonald, L ^a   Rossiter, Shannon ^b   Mackinson, Constance ^c   Wang, Yong Yu ^c   Johnson, Susan ^d   Sullivan, Maureen ^d   Sokolow, Robert ^e   DeBess, Emilio ^e   Gilbert, Laura ^f   Benson, James A ^f   Hill, Bertha ^a   Angulo, Frederick J ^b,g  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d MINNESOTA DEPARTMENT OF HEALTH   (United States)

^e Oregon Health Division   (United States)

^f Georgia Division of Public Health   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G; RIFAMPICIN; STREPTOGRAMIN; STREPTOMYCIN; TETRACYCLINE; VIRGINIAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; CHICKEN; ENTEROCOCCUS FAECIUM; FECES ANALYSIS; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

ANIMAL FEED; ANIMALS; ANTI-BACTERIAL AGENTS; CHICKENS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECIUM; FECES; HUMANS; MEAT; MICROBIAL SENSITIVITY TESTS; UNITED STATES; VIRGINIAMYCIN;

EID: 0035909655     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa010805     Document Type: Article

References (40)

1. Antimicrobial susceptibility patterns of enterococci causing infections in Europe
2. Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States
3. Antimicrobial resistance in key bloodstream bacterial isolates: Electronic surveillance with the Surveillance Network Database - USA
4. Summary of notifiable diseases, United States, 1998
5. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms
6. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man
7. vanA-Mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry
8. Influence of oral glycopeptides on the fecal flora of human volunteers: Selection of highly glycopeptide-resistant enterococci
9. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients
10. VRE and meat
11. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium
12. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Netherlands
13. Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of the Netherlands: Evidence for transmission of vancomycin resistance from animals to humans?
14. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe
15. Decrease of vancomycin-resistant enterococci in poultry meat after avoparcin ban
16. Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry
17. Continuing high prevalence of VanA-type vancomycin-resistant enterococci on Norwegian poultry farms three years after avoparcin was banned
18. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada
19. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin
20. Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium BM4145
21. Antimicrobial resistance in enterococci isolated from turkey flocks fed virginiamycin
22. High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in the Netherlands: Is the addition of antibiotics to animal feeds to blame?
23. Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark
24. Occurrence of satA and vgb genes in streptogramin-resistant Enterococcus faecium isolates of animal and human origins in the Netherlands
25. Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in western Europe
26. Use of cephalexin-aztreonam-arabinose agar for selective isolation of Enterococcus faecium
27. Enterococcus
28. The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans
29. Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model
30. Persistence of vancomycin-resistant Enterococcus faecium gastrointestinal tract colonization in antibiotic-treated mice
31. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract
32. Detection of the satA gene and transferability of virginiamycin resistance in Enterococcus faecium from food-animals
33. Horizontal transfer of the satA gene encoding streptogramin A resistance between isogenic Enterococcus faecium strains in the gastrointestinal tract of gnotobiotic rats
34. Risk assessment of the public health impact of streptogramin resistance in Enterococcus faecium attributable to the use of streptogramins in animals: Request for comments and for scientific data and information